Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Role for dual individualization with cefmenoxime.

J J Schentag, I L Smith, D J Swanson

    The American Journal of Medicine
    |December 21, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patient engagement in the Continuing Professional Development programs within the department of radiation oncology at the University of Toronto (UTDRO): A qualitative study.

    Journal of medical imaging and radiation sciences·2022
    Same author

    The generation of two specific cancer costing algorithms using Ontario administrative databases.

    Current oncology (Toronto, Ont.)·2019
    Same author

    The aCORN Backscatter-Suppressed Beta Spectrometer.

    Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment·2019
    Same author

    aCORN: An experiment to measure the electron-antineutrino correlation coefficient in free neutron decay.

    The Review of scientific instruments·2017
    Same author

    Does the Time of Radiotherapy Affect Treatment Outcomes? A Review of the Literature.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2016
    Same author

    Treatment of severe, chronic hand eczema: results from a UK-wide survey.

    Clinical and experimental dermatology·2016
    Same journal

    Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

    The American journal of medicine·2026
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric panniculitis.

    The American journal of medicine·2026
    See all related articles

    Optimizing cefmenoxime dosage using dual individualization in critical care patients with nosocomial pneumonia led to predictable bacterial eradication and shorter treatment durations. This approach enhances antibiotic therapy effectiveness.

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Critical Care Medicine

    Background:

    • Nosocomial pneumonia poses a significant challenge in critical care settings.
    • Antibiotic resistance necessitates optimized dosing strategies for effective treatment.
    • Understanding cefmenoxime concentration-effect relationships is crucial for gram-negative bacterial infections.

    Purpose of the Study:

    • To retrospectively explore cefmenoxime concentration/effect relationships in patients with nosocomial pneumonia.
    • To derive a dynamic response concentration for cefmenoxime against gram-negative bacteria.
    • To evaluate the efficacy of a dual individualization dosage optimization method for predictable bacterial eradication.

    Main Methods:

    • Retrospective analysis of cefmenoxime concentrations and bacterial growth kinetics in 14 critical care patients.

    Related Experiment Videos

  • In vitro studies using the Abbott MS-2 Research System to determine dynamic response concentration.
  • Prospective evaluation of dual individualization in 18 patients with optimized cefmenoxime dosage.

    • Main Results:

    • Bacterial eradication rates were predictable based on cefmenoxime pharmacokinetics and concentration-inhibition relationships.
    • Prospective dual individualization resulted in a predictable day of bacterial eradication.
    • Optimized dosage was associated with a significantly shorter duration of treatment (p < 0.05).

    Conclusions:

    • Dual individualization, based on pharmacokinetic and pharmacodynamic data, allows for predictable antibiotic dosage optimization.
    • Precise optimization of cefmenoxime dosage can lead to predictable bacterial eradication from infection sites.
    • This approach shows promise for improving antibiotic therapy outcomes in critical care.